Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
398 studies found for:    biogen | biogen
Show Display Options
Rank Status Study
21 Completed Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient
Condition: Healthy
Intervention: Drug: BG00012
22 Available Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)
Condition: Infantile-onset Spinal Muscular Atrophy
Intervention: Drug: nusinersen
23 Completed Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Interferon-beta-1a;   Drug: methylprednisolone
24 Completed A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)
Condition: Relapsing Forms of Multiple Sclerosis
Interventions: Procedure: Plasma exchange;   Drug: natalizumab treatment
25 Completed A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis
Condition: Exercise
Intervention:
26 Completed Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: BIIB014;   Other: [11C]SCH442416
27 Completed Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: BIIB014;   Drug: Placebo
28 Not yet recruiting Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
Conditions: Rheumatoid Arthritis;   Axial Spondyloarthritis
Interventions: Biological: Benepali;   Biological: Enbrel
29 Not yet recruiting Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Interventions: Drug: BIIB074;   Drug: Placebo
30 Recruiting Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus (SLE);   Active Cutaneous Lupus Erythematosus (CLE)
Interventions: Drug: BIIB059;   Drug: Placebo
31 Recruiting Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: natalizumab;   Drug: Placebo
32 Recruiting Single and Multiple Dose Study of BIIB067 in Adults With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: BIIB067;   Other: Placebo
33 Recruiting Methodology Study of Novel Outcome Measures to Assess Progression of ALS
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention:
34 Recruiting Plegridy Satisfaction Study in Participants
Condition: Relapsing-Remitting Multiple Sclerosis (RRMS)
Intervention: Drug: peginterferon beta-1a
35 Recruiting Tecfidera and the Gut Microbiota
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: dimethyl fumarate;   Drug: injectable MS DMT
36 Recruiting Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease
Conditions: Parkinson's Disease;   Healthy
Interventions: Drug: BIIB054;   Drug: Placebo
37 Recruiting Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: dimethyl fumarate;   Drug: Interferon β-1a
38 Recruiting Dimethyl Fumarate (DMF) Observational Study
Condition: Multiple Sclerosis
Intervention: Drug: dimethyl fumarate
39 Recruiting Tysabri Observational Program
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: natalizumab
40 Terminated Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL
Condition: B-Cell Chronic Lymphocytic Leukemia
Intervention: Drug: CNF2024 (BIIB021)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.